0000950170-24-042372.txt : 20240405 0000950170-24-042372.hdr.sgml : 20240405 20240405185809 ACCESSION NUMBER: 0000950170-24-042372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240404 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Hanjoon Alex CENTRAL INDEX KEY: 0001919209 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 24827788 MAIL ADDRESS: STREET 1: C/O FLUIDIGM CORPORATION STREET 2: 2 TOWER PLACE, SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC. CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLUIDIGM CORP DATE OF NAME CHANGE: 20011113 4 1 ownership.xml 4 X0508 4 2024-04-04 0001162194 STANDARD BIOTOOLS INC. LAB 0001919209 Kim Hanjoon Alex C/O STANDARD BIOTOOLS INC. 2 TOWER PLACE, STE 2000 SOUTH SAN FRANCISCO CA 94080 false true false false Chief Operating Officer false Common Stock 2024-04-04 4 M false 70183 0 A 140366 D Common Stock 2024-04-05 4 A false 70702 0 A 211068 D Restricted Stock Units 2024-04-04 4 M false 70183 0 D Common Stock 70183 140366 D On April 11, 2023, the Reporting Person was granted a target amount of 77,185 performance-based restricted stock units ("RSUs") under the Issuer's 2011 Equity Incentive Plan, as amended. Each RSU represent the right, upon achievement of certain pre-established performance criteria, to receive one share of the Issuer's common stock, subject to vesting conditions. On April 5, 2024, the Board of Directors of the Issuer determined that certain of the RSU performance-based conditions were met resulting in the vesting of 70,702 RSUs as of March 31, 2024. Each RSU represents the contingent right to receive one share of the Issuer's common stock. On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023. /s/ Hanjoon Alex Kim by Agnieszka Gallagher, Attorney-in-Fact 2024-04-05